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Abstract
Background: Blood urea nitrogen (BUN) has been shown to be associated with adverse cardiovascular 
disease outcomes. The aim of the present study was to evaluate the prognostic role of BUN in patients 
with acute aortic dissection (AAD). Hypothesis: BUN has correlation with in-hospital mortality of 
patients with AAD.
Methods: Patients admitted to the emergency room within the first 24 h of onset of AAD were included 
in the study. BUN levels were measured on admission and the endpoints were mortality during hospi-
talization after receiving surgical or endovascular repair. 
Results: A total of 192 patients with AAD were enrolled. During hospitalization, 19 patients died and 
173 patients survived. Increased levels of BUN (8.9 [7.0–9.7] vs. 6.0 [5.1–7.2] mmol/L, p < 0.001) 
were found in non-survivors compared with those survived. Using multivariable logistic analysis, 
BUN was an independent predictor of in-hospital mortality in patients with AAD (OR 1.415, 95% CI 
1.016–1.971, p = 0.040). Furthermore, using receiver operating characteristic analysis, the optimal 
cutoff value for BUN was 6.95 mmol/L. Under this value, the area under the curve was 0.785 (95% CI 
0.662–0.909, p < 0.001) and the sensitivity and specificity to predict in-hospital mortality was 78.9%, 
and 72.2%, respectively.
Conclusions: Admission BUN levels were an independent predictor for in hospital mortality in pa-
tients with AAD. (Cardiol J 2018; 25, 3: 371–376)
Key words: blood urea nitrogen, acute aortic dissection, in-hospital mortality
Introduction
The relationship between renal dysfunction 
and adverse cardiovascular disease outcomes 
have been well established in patients with coro-
nary artery disease (CAD) [1] and in those with 
heart failure [2]. Prior studies utilizing serum 
creatinine, estimates of glomerular filtration 
rate (eGFR) or blood urea nitrogen (BUN) to 
investigate the prognostic role of renal dysfunc-
tion in cardiovascular disease have found that 
BUN is more sensitive than creatinine and eGFR 
in predicting poor clinical outcomes [1, 3, 4]. 
In fact, BUN has also been demonstrated to be 
a valid biomarker for disease severity and progno-
sis in many other conditions such as community-
acquired pneumonia [5], acute pancreatitis [6] and 
acute intracerebral hemorrhage [7]. 
Acute aortic dissection (AAD) is a life-threat-
ening disorder that necessitates immediate man-
agement. Previous studies have demonstrated that 
kidney injury is a risk factor for both short and 
long term mortality in patients with AAD [8, 9]. 
However, these studies used serum creatinine 
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as a surrogate marker for renal dysfunction and 
whether BUN could also provide some prognostic 
significance in these patients is unknown. Hence, 
the aim of the present study was to evaluate the 
relationship between BUN and in hospital mortality 
in patients admitted with AAD. 
Methods
Study population
Herein is retrospectively investigated the 
medical records of patients with AAD admitted to 
the First Affiliated Hospital of Wenzhou Medical 
University between December 2012 and June 2016. 
The study was reviewed and approved by the ethics 
committee of the hospital and informed consent 
was waived due to its retrospective nature. 
The diagnosis of AAD was confirmed by multi-
detector computed tomography scan and the type 
of AAD was classified in accordance with Stanford 
University criteria. Patients were included in the 
present study if they fulfilled the following criteria: 
(1) the time interval between symptoms onset 
and hospital admission of ≤ 24 h; (2) receiving 
surgical or endovascular repair for AAD du-
ring hospitalization. Exclusion criteria included: 
(1) presence of AAD for more than 24 h; (2) diagnosis 
with Marfan syndrome; (3) prior history of aortic 
dissection (AD). 
Treatment
For patients with confirmed diagnosis of AD, 
urapidil, sodium nitroprusside or nitroglycerine 
were was administered intravenously to reduce 
systolic blood pressure (SBP) to 100–120 mmHg. 
Beta-blocker was administered to all patients ex-
cept those with the contraindication. 
All type A AD patients and a small part of 
type B AD patients underwent surgery repair via 
cardiopulmonary bypass. Endovascular repair was 
performed using commercially available endografts 
with the patients under general anesthesia. 
Data collection
The following clinical data were collected on 
admission: age, sex, presence of hypertension, CAD, 
dyslipidemia, diabetes mellitus (DM), smoking and 
drinking habits, type of AAD, aortic diameter, blood 
pressure, heart rate, and laboratory data. 
Endpoint
The study endpoint was defined as all-cause 
mortality during hospitalization. 
Statistical analysis
Normality of continuous data was assessed 
using the Shapiro-Wilk test. Continuous variables 
are presented as the mean ± standard deviation or 
median and interquartile range according to whether 
they follow normal distributions. Categorical vari-
ables are presented as proportions. Comparisons be-
tween groups were performed with unpaired Student 
t tests for normally distributed continuous variables 
and Wilcoxon Mann-Whitney tests for non-normally 
distributed continuous variables. Categorical vari-
ables were compared by c2 tests or Fisher’s exact test 
when appropriate. Univariate analysis and multiple 
logistic regression analysis were used to identify the 
predictors of in-hospital mortality. Receiver operat-
ing characteristic (ROC) analysis was performed to 
determine the cut-off value for BUN in predicting in-
hospital mortality with high sensitivity and specificity. 
A p value < 0.05 was considered to be statistically sig-
nificant. All the statistical analyses were performed 
using SPSS statistical software, version 19.0 (SPSS 
Inc., Chicago, Illinois).
Results
Baseline clinical characteristics
Six hundred twenty six patients were identi-
fied with a diagnosis of AD, of whom 251 were 
admitted within 24 h after onset of symptoms. 
Among them, 8 patients diagnosed with Marfan 
syndrome, 9 patients with prior history of AD and 
42 patients died during hospitalization with con-
servative treatment were excluded from analysis. 
A total of 192 patients met our eligibility criteria 
and were included in the present study. During 
hospitalization, 19 patients died and 173 patients 
survived. 
Patient characteristics are shown in Table 1. 
There were no significant differences in sex, 
hypertension, CAD, dyslipidemia, DM, smoking, 
alcohol use, aortic diameter, heart rate and neu-
trophil counts between the two groups. Compared 
with survivors, the non-survivors were older 
(62 [50–66] vs. 50 [44–60] years, p = 0.03), had 
a higher percentage of type A AD (78.9% vs. 
43.9%, p = 0.003). The non-survivors had a sig-
nificantly lower SBP (116.2 ± 26.0 vs. 145.6 ± 
± 26.0 mmHg, p < 0.001), diastolic blood pres-
sure (DBP; 66.6 ± 15.5 vs. 80.2 ± 18.6 mmHg, 
p = 0.003), and hemoglobin (122 [111–133] vs. 
132 [122–144] g/L, p = 0.006) on admission. In 
addition, white blood cell counts (14.8 [13.1–18.0] 
vs. 13.2 [11.2–15.8] ×109/L, p = 0.047), creatinine 
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(127.0 [83.0–150.0] vs. 76.0 [63.0–96.0] mmol/L, 
p < 0.001) and BUN (8.9 [7.0–9.7] vs. 6.0 [5.1–7.2] 
mmol/L, p < 0.001) levels were higher in the non-
survivor group than in the survivor group. 
Predictors for in-hospital mortality
Logistic regression was performed to iden-
tify potential predictors for in-hospital mortality 
in patients with AAD. Variables included in the 
univariable logistic regression analysis for in-
hospital mortality were age, type A AD, SBP, DBP, 
white blood cell counts, hemoglobin, creatinine 
and BUN. Except for white blood cell counts, all 
variables included were significantly associated 
with in-hospital mortality in univariable logistic 
regression (Table 2). The multivariable logistic 
regression model for in-hospital mortality included 
all variables from the univariable analysis. The only 
variables that remained as independent predictors 
of in-hospital mortality were age (odds ratio [OR] 
1.059, 95% confidence interval [CI] 1.003–1.119, 
p = 0.039), SBP (OR 0.962, 95% CI 0.928–0.998, 
Table 1. Baseline characteristics of the patients.
Variable All patients (n = 192) Survivor (n = 173) Non-survivor (n = 19) P
Age [years] 51 (44-62) 50 (44-60) 62 (50-66) 0.03
Male 151 (78.6%) 135 (78.0%) 16 (84.2%) 0.388
Hypertension 137 (71.4%) 122 (70.5%) 15 (78.9%) 0.316
Coronary artery disease 1 (0.5%) 1 (0.6%) 0 (0%) 0.901
Dyslipidemia 1 (0.5%) 1 (0.6%) 0 (0%) 0.901
Diabetes mellitus 7 (3.6%) 6 (3.5%) 1 (5.3%) 0.524
Smoking 66 (34.4%) 61 (35.3%) 5 (26.3%) 0.612
Alcohol use 41 (21.4%) 39 (22.5%) 2 (10.5%) 0.181
Type A AD 91 (47.4%) 76 (43.9%) 15 (78.9%) 0.003
SBP [mmHg] 142.7 ± 27.4 145.6±26.0 116.2 ± 26.0 < 0.001
DBP [mmHg] 78.8 ± 18.7 80.2 ± 18.6 66.6 ± 15.5 0.003
Aortic diameter [mm] 39 (36–43) 39 (36–43) 41 (35–45) 0.329
Heart rate [bpm] 80.9 ± 16.6 80.5±16.3 84.4 ± 19.0 0.333
White blood cell [×109/L] 13.5 (11.2–16.0) 13.2 (11.2–15.8) 14.8 (13.1–18.0) 0.047
Neutrophil [×109/L] 12.0 ± 3.7 11.8 ± 3.6 13.3 ± 4.3 0.100
Hemoglobin [g/L] 132 (122–144) 132 (122–144) 122 (111–133) 0.006
Creatinine [mmol/L] 78.0 (64.0–102.8) 76.0 (63.0–96.0) 127.0 (83.0–150.0) < 0.001
BUN [mmol/L] 6.1 (5.2–7.6) 6.0 (5.1–7.2) 8.9 (7.0–9.7) < 0.001
Data are expressed as mean ± standard deviation, median (25th–75th percentile) or the number (percentages) of patients. The bold values 
indicate statistical significance; AD — aortic dissection; BUN — blood urea nitrogen; DBP — diastolic blood pressure; SBP — systolic blood 
pressure
Table 2. Univariable logistic regression for in-hospital mortality.
Variable OR 95% CI P
Age 1.037 0.999–1.075 0.0054
Type A AD 4.786 1.526–15.011 0.007
SBP [mmHg] 0.957 0.929–0.976 < 0.001
DBP [mmHg] 0.960 0.934–0.987 0.004
White blood cell [×109/L] 1.116  0.997–1.249 0.057
Hemoglobin [g/L] 0.965 0.940–0.992 0.010
Creatinine [mmol/L] 1.005 1.000–1.010 0.037
BUN [mmol/L] 1.330 1.118–1.582 0.001
CI — confidence interval; OR — odds ratio; rest abbreviations as in Table 1
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p = 0.0037) and BUN (OR 1.415, 95% CI 1.016– 
–1.971, p = 0.040) (Table 3).
Given the high mortality rates in patients 
with type A AD and those who undergo surgery 
treatment, subgroup analysis was performed by 
the type of AD and treatment. In patients with 
type A AD, BUN was associated with high 
risk of in-hospital mortality (OR 1.663, 95% 
CI 1.006–2.747, p = 0.047). For patients with 
type B AD, BUN was not an independent pre-
dictor for in-hospital mortality. As for the sub-
group, stratified by surgical or endovascular 
repair, BUN independently predicted in-hospi-
tal mortality (OR 1.811, 95% CI 1.190–2.756, 
p = 0.006; OR 1.379, 95% CI 1.023–1.859, 
p = 0.035, respectively) (Fig. 1).
ROC analysis
ROC analysis yielded an area under the curve 
(AUC) statistic of 0.785 (95% CI 0.662–0.909, 
p < 0.001) and the cut-off value of BUN to predict 
in-hospital mortality was 6.95 (sensitivity 78.9%, 
specificity 72.2%) (Table 4, Fig. 2).
Discussion
The main findings of the present study were 
that admission BUN levels were independently as-
sociated with in-hospital mortality in patients with 
AAD admitted within 24 h after onset of symptoms. 
When BUN was ≥ 6.95 mmol/L, the sensitivity and 
specificity for in-hospital mortality were 78.9% and 
72.2%, respectively.
Table 3. Multivariable logistic regression for in-hospital mortality.
Variable OR 95% CI P
Age 1.059 1.003–1.119 0.039
Type A AD 2.099 0.451–9.774 0.345
SBP [mmHg] 0.962 0.928–0.998 0.037
DBP [mmHg] 1.000 0.955–1.047 0.992
White blood cell [×109/L] 1.113 0.946–1.310 0.196
Hemoglobin [g/L] 0.983 0.943–1.026 0.435
Creatinine [mmol/L] 0.996 0.984–1.007 0.469
BUN [mmol/L] 1.415 1.016–1.971 0.040
CI — confidence interval; OR — odds ratio; rest abbreviations as in Table 1.
Table 4. Diagnostic value of blood urea nitrogen for in-hospital mortality.
AUC Cut-off value SE 95% CI P Sensitivity Specificity
0.785 6.95 0.063 0.662–0.909 < 0.001 0.789 0.722
AUC — area under the curve; CI — confidence interval; SE — standard error
Figure 1. Odds ratios of blood urea nitrogen for predicting in-hospital mortality according to the type of acute aortic 
dissection (AAD) and treatment; CI — confidence interval; EVR — endovascular repair. 
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Urea is synthesized in liver via protein catabo-
lism and blood urea is freely filtered at the glo-
merulus and undergoes tubular reabsorption. In the 
absence of enhanced protein catabolism, such as se-
vere infection and burning, trauma, glucocorticoids 
therapy or high protein diet, urea levels in blood is 
determined by the GFR and tubular reabsorption. 
In the setting of AAD, hemodynamic disturbances 
lead to activation of the neurohormonal axis, re-
sulting in increased sympathetic nervous system 
[10] and renin–angiotensin–aldosterone system 
activity [11]. Increased angiotensin and adrenergic 
stimulation decrease renal urea excretion via ef-
fects on vascular, glomerular, and tubular effects on 
the kidney. These neurohormonal responses cause 
renal vasoconstriction, decreases in glomerular 
ultrafiltration, and increases in proximal tubular 
sodium and water reabsoption. Consequently, 
the fluid delivery in the collecting conduct will 
decrease and urine flow will slow. Because urea 
reabsorption in the distal tubule is urine flow 
dependent, the decreased slowing of tubular flow 
will enhance urea reabsorption [12]. Besides, AAD 
can cause low cardiac output by forming pericar-
dial effusion or myocardial ischemia secondary to 
coronary artery involvement. In order to preserve 
systemic perfusion, arginine vasopressin (AVP) is 
released as a compensatory mechanism. AVP can 
rapidly increase urea permeability in the collecting 
duct through phosphorylation and apical plasma-
membrane accumulation of the urea transporter 
A1 (UT-A1) and subsequently lead to increased 
reabsorption of urea in the collecting duct [13]. 
Therefore, increased BUN level could be regarded 
as a surrogate marker for hemodynamic and neu-
rohormonal alternations in AAD.
The prognostic implication of increased BUN 
has been evaluated in patients with acute de-
compensated heart failure (ADHF). Studies have 
demonstrated that in the setting of ADHF, patients 
with high admission BUN level had low cumulative 
survival rate [14, 15]. In addition, Miura et al. [16] 
have shown that in patients admitted for ADHF, a 
BUN increase during hospitalization also indicated 
worse long-term prognosis, independent of renal 
function. Moreover, increased BUN is also associ-
ated with worse prognosis in a wide spectrum of 
patients with acute coronary syndromes [1, 17]. 
However, few data are available on the relationship 
between BUN and clinical outcomes in patients 
with AAD. The present findings indicate for the 
first time that in patients with AAD receiving 
surgical or endovascular repair, high admission 
BUN levels were associated with high in-hospital 
mortality. BUN may be a promising marker for risk 
stratification in patients with AAD.
Limitations of the study
This study has several limitations. First, be-
cause of its observational nature, some factors that 
may have influenced the outcome of AD were 
unavailable, such as D-dimer and C-reactive protein. 
Second, this study was carried out in patients receiv-
ing surgical or endovascular repair for AAD, exclud-
ing those receiving conservative treatment, which 
could limit results to extrapolate to a wider group 
of patients. Furthermore, this study was carried 
out in a single institution and enrolled a relatively 
small number of patients, which precluded subgroup 
analysis. A future prospective study with a larger 
sample size is required to confirm these findings.
Conclusions
In summary, the present study found that 
elevated BUN levels were an independent predic-
tor of in-hospital mortality in patients with AAD 
receiving surgical or endovascular repair. Serum 
BUN may serve as a simple marker to identify high 
risk patients.
Figure 2. Receiver operating characteristic curve of 
blood urea nitrogen for predicting in-hospital mortality 
in patients with acute aortic dissection.
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